Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus Deferoxamine for AKI Prevention in Hypotension
NCT00870883Phase 2Completed
- Sponsor
- Universidade do Extremo Sul Catarinense
- Start
- Mar 2009
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine, deferoxamine in acute kidney injury (AKI), sponsored by Universidade do Extremo Sul Catarinense. Started Mar 2009; status: completed.
02
Drugs
acetylcysteinedeferoxamine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00870883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870883.